Laura A. Hehl

Laura A. Hehl

Auto-generated profile, based on publicly available information

Laura A. Hehl

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Molecular Cell
Verified
Journal Article
Open access
DSDawafuti Sherpa
Dawafuti Sherpa
JCJakub Chrustowicz
Jakub Chrustowicz
SQShuai Qiao
Shuai Qiao
CLChristine R. Langlois
Christine R. Langlois
LHLaura A. Hehl
Laura A. Hehl
BSBrenda A. Schulman
Brenda A. Schulman
How are E3 ubiquitin ligases configured to match substrate quaternary structures? Here, by studying the yeast GID complex (mutation of which causes deficiency in glucose-induced degradation of gluconeogenic enzymes), we discover supramolecular chelate assembly as an E3 ligase strategy for targeting an oligomeric substrate. Cryoelectron microscopy (cryo-EM) structures show that, to bind the tetrameric substrate fructose-1,6-bisphosphatase (Fbp1), two minimally functional GID E3s assemble into the 20-protein Chelator-GIDSR4, which resembles an organometallic supramolecular chelate. The Chelator-GIDSR4 assembly avidly binds multiple Fbp1 degrons so that multiple Fbp1 protomers are simultaneously ubiquitylated at lysines near the allosteric and substrate binding sites. Importantly, key structural and biochemical features, including capacity for supramolecular assembly, are preserved in the human ortholog, the CTLH E3. Based on our integrative structural, biochemical, and cell biological data, we propose that higher-order E3 ligase assembly generally enables multipronged targeting, capable of simultaneously incapacitating multiple protomers and functionalities of oligomeric substrates.

26 May 2025 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
SMSamuel A. Maiwald
Samuel A. Maiwald
LSLaura A. Schneider
Laura A. Schneider
RVRonnald Vollrath
Ronnald Vollrath
JLJoanna Liwocha
Joanna Liwocha
MMMatthew D. Maletic
Matthew D. Maletic
BSBrenda A. Schulman
Brenda A. Schulman
Regulation by ubiquitin depends on E3 ligases forging chains of specific topologies, yet the mechanisms underlying the generation of atypical linkages remain largely elusive. Here we utilize biochemistry, chemistry, and cryo-EM to define the catalytic architecture producing K29 linkages and K29/K48 branches for the human HECT E3 TRIP12. TRIP12 resembles a pincer. One pincer side comprises tandem ubiquitin-binding domains, engaging the proximal ubiquitin to direct its K29 towards the ubiquitylation active site, and selectively capturing a distal ubiquitin from a K48-linked chain. The opposite pincer side—the HECT domain—precisely juxtaposes the ubiquitins to be joined, further ensuring K29 linkage specificity. Comparison to the prior structure visualizing K48-linked chain formation by UBR5 reveals a similar mechanism shared by two human HECT enzymes: parallel features of the E3s, donor and acceptor ubiquitins configure the active site around the targeted lysine, with E3-specific domains buttressing the acceptor for linkage-specific polyubiquitylation.

27 June 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
DBDavid A. Pérez Berrocal
David A. Pérez Berrocal
TVThimmalapura M. Vishwanatha
Thimmalapura M. Vishwanatha
DHDaniel Horn‐Ghetko
Daniel Horn‐Ghetko
JBJ. Josephine Botsch
J. Josephine Botsch
LHLaura A. Hehl
Laura A. Hehl
MMMonique Mulder
Monique Mulder
Protein post‐translational modification with ubiquitin (Ub) is a versatile signal regulating almost all aspects of cell biology, and an increasing range of diseases is associated with impaired Ub modification. In this light, the Ub system offers an attractive, yet underexplored route to the development of novel targeted treatments. A promising strategy for small molecule intervention is posed by the final components of the enzymatic ubiquitination cascade, E3 ligases, as they determine the specificity of the protein ubiquitination pathway. Here, we present UbSRhodol, an autoimmolative Ub‐based probe, which upon E3 processing liberates the pro‐fluorescent dye, amenable to profile the E3 transthiolation activity for recombinant and in cell‐extract E3 ligases. UbSRhodol enabled detection of changes in transthiolation efficacy evoked by enzyme key point mutations or conformational changes, and offers an excellent assay reagent amenable to a high‐throughput screening setup allowing the identification of small molecules modulating E3 activity.

7 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
LHLaura A. Hehl
Laura A. Hehl
DHDaniel Horn-Ghetko
Daniel Horn-Ghetko
JPJ. Rajan Prabu
J. Rajan Prabu
RVRonnald Vollrath
Ronnald Vollrath
DVD. Tung Vu
D. Tung Vu
BSBrenda A. Schulman
Brenda A. Schulman
Ubiquitin chain formation by HECT catalytic domain-containing E3 ligases regulates vast biology, yet the structural mechanisms remain unknown. We employed chemistry and cryo-EM to visualize stable mimics of the intermediates along K48-linked ubiquitin chain formation by the human E3, UBR5. The structural data reveal a ≈620 kDa UBR5 dimer as the functional unit, comprising a scaffold with flexibly-tethered ubiquitin-binding UBA domains, and elaborately arranged HECT domains. Chains are forged by a UBA domain capturing an acceptor ubiquitin, with its K48 lured into the active site by numerous interactions between the acceptor ubiquitin, manifold UBR5 elements, and the donor ubiquitin. The cryo-EM reconstructions allow defining conserved HECT domain conformations catalyzing ubiquitin transfer from E2 to E3, and from E3. Our data show how a full-length E3, ubiquitins to be adjoined, E2, and intermediary products guide a feed-forward HECT domain conformational cycle establishing a highly efficient, broadly targeting, K48-linked ubiquitin chain forging machine.

21 November 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
LSLaura A. Schneider
Laura A. Schneider
ABAlexandra M. Bendel
Alexandra M. Bendel
RBRegina Baur
Regina Baur
NTNicolas H. Thomä
Nicolas H. Thomä

27 June 2023 in Angewandte Chemie
Verified
Journal Article
Open access
DBDavid A. Pérez Berrocal
David A. Pérez Berrocal
TVThimmalapura M. Vishwanatha
Thimmalapura M. Vishwanatha
DHDaniel Horn‐Ghetko
Daniel Horn‐Ghetko
JBJ. Josephine Botsch
J. Josephine Botsch
LHLaura A. Hehl
Laura A. Hehl
MMMonique Mulder
Monique Mulder
Protein post‐translational modification with ubiquitin (Ub) is a versatile signal regulating almost all aspects of cell biology, and an increasing range of diseases is associated with impaired Ub modification. In this light, the Ub system offers an attractive, yet underexplored route to the development of novel targeted treatments. A promising strategy for small molecule intervention is posed by the final components of the enzymatic ubiquitination cascade, E3 ligases, as they determine the specificity of the protein ubiquitination pathway. Here, we present UbSRhodol, an autoimmolative Ub‐based probe, which upon E3 processing liberates the pro‐fluorescent dye, amenable to profile the E3 transthiolation activity for recombinant and in cell‐extract E3 ligases. UbSRhodol enabled detection of changes in transthiolation efficacy evoked by enzyme key point mutations or conformational changes, and offers an excellent assay reagent amenable to a high‐throughput screening setup allowing the identification of small molecules modulating E3 activity.